nach oben

Erschienen in:

30.04.2019 | Special Section: Rectal Cancer

MR staging of anal cancer: what the radiologist needs to know

verfasst von: Jennifer S. Golia Pernicka, Shannon P. Sheedy, Randy D. Ernst, Bruce D. Minsky, Dhakshinamoorthy Ganeshan, Gaiane M. Rauch

Erschienen in: Abdominal Radiology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Anal canal cancer is a rare disease and squamous cell carcinoma is the most common histologic subtype. Traditionally, anal cancer is imaged with CT and PET/CT for purposes of TNM staging. With the increased popularity of MRI for rectal cancer evaluation, MRI has become increasingly utilized for local staging of anal cancer. In this review, we focus on the necessary information radiologists need to know to understand this rare and unique disease and to be familiar with staging of anal cancer on MRI.

Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA: a cancer journal for clinicians 68 (1):7-30. https://doi.org/10.3322/caac.21442

National Comprehensive Cancer Network Anal Carcinoma (Version 2. 2018). https://www.nccn.org/professionals/physician_gls/pdf/anal.pdf. Accessed January 9, 2019

Nigro ND, Vaitkevicius VK, Considine B, Jr. (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17 (3):354-356

NIH Surveillance EaERP SEER Stat Fact Sheets: Anal Cancer. Available at http://seer.cancer.gov/statfacts/html/anus.html. Accessed: January 3, 2019.

American Cancer Society Cancer Facts & Figures 2018. Available at https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf. Accessed: October 26, 2018.

Nelson VM, Benson AB, 3rd (2017) Epidemiology of Anal Canal Cancer. Surgical oncology clinics of North America 26 (1):9-15. https://doi.org/10.1016/j.soc.2016.07.001

Ryan DP, Compton CC, Mayer RJ (2000) Carcinoma of the anal canal. The New England journal of medicine 342 (11):792-800. https://doi.org/10.1056/nejm200003163421107

Chiu S, Joseph K, Ghosh S, Cornand RM, Schiller D (2015) Reasons for delays in diagnosis of anal cancer and the effect on patient satisfaction. Canadian family physician Medecin de famille canadien 61 (11):e509-516

Morris VK, Rashid A, Rodriguez-Bigas M, Das P, Chang G, Ohinata A, Rogers J, Crane C, Wolff RA, Eng C (2015) Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal. The oncologist 20 (11):1247-1252. https://doi.org/10.1634/theoncologist.2015-0091

10.

Darragh TM, Colgan TJ, Thomas Cox J, Heller DS, Henry MR, Luff RD, McCalmont T, Nayar R, Palefsky JM, Stoler MH, Wilkinson EJ, Zaino RJ, Wilbur DC (2013) The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. International journal of gynecological pathology: official journal of the International Society of Gynecological Pathologists 32 (1):76-115. https://doi.org/10.1097/pgp.0b013e31826916c7

11.

Watson AJ, Smith BB, Whitehead MR, Sykes PH, Frizelle FA (2006) Malignant progression of anal intra-epithelial neoplasia. ANZ journal of surgery 76 (8):715-717. https://doi.org/10.1111/j.1445-2197.2006.03837.x

12.

Erden A (2018) MRI of anal canal: normal anatomy, imaging protocol, and perianal fistulas: Part 1. Abdominal radiology (New York) 43 (6):1334-1352. https://doi.org/10.1007/s00261-017-1305-2

13.

Ciombor KK, Ernst RD, Brown G (2017) Diagnosis and Diagnostic Imaging of Anal Canal Cancer. Surgical oncology clinics of North America 26 (1):45-55. https://doi.org/10.1016/j.soc.2016.07.002

14.

Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study (2006). BMJ (Clinical research ed) 333 (7572):779. https://doi.org/10.1136/bmj.38937.646400.55

15.

Nougaret S, Reinhold C, Mikhael HW, Rouanet P, Bibeau F, Brown G (2013) The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the “DISTANCE”? Radiology 268 (2):330-344. https://doi.org/10.1148/radiol.13121361

16.

Shihab OC, Moran BJ, Heald RJ, Quirke P, Brown G (2009) MRI staging of low rectal cancer. European radiology 19 (3):643-650. https://doi.org/10.1007/s00330-008-1184-6

17.

Society of Abdominal Radiology Rectal Cancer DFP. https://www.abdominalradiology.org/page/DFPrectalcancer. Accessed December 17, 2019

18.

Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, Fenlon HM, Gollub MJ, Gourtsoyianni S, Halligan S, Hoeffel C, Kim SH, Laghi A, Maier A, Rafaelsen SR, Stoker J, Taylor SA, Torkzad MR, Blomqvist L (2018) Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. European radiology 28 (4):1465-1475. https://doi.org/10.1007/s00330-017-5026-2

19.

Kaur H, Choi H, You YN, Rauch GM, Jensen CT, Hou P, Chang GJ, Skibber JM, Ernst RD (2012) MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics: a review publication of the Radiological Society of North America, Inc 32 (2):389-409. https://doi.org/10.1148/rg.322115122

20.

Nougaret S, Rouanet P, Molinari N, Pierredon MA, Bibeau F, Azria D, Lemanski C, Assenat E, Duffour J, Ychou M, Reinhold C, Gallix B (2012) MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy. Radiology 263 (2):409-418. https://doi.org/10.1148/radiol.12111263

21.

Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D, European Society for Medical O, European Society of Surgical O, European Society of R, Oncology (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol 40 (10):1165-1176. https://doi.org/10.1016/j.ejso.2014.07.030

22.

Stewart DB, Gaertner WB, Glasgow SC, Herzig DO, Feingold D, Steele SR, Prepared on Behalf of the Clinical Practice Guidelines Committee of the American Society of C, Rectal S (2018) The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018). Dis Colon Rectum 61 (7):755-774. https://doi.org/10.1097/dcr.0000000000001114

23.

Moureau-Zabotto L, Vendrely V, Abramowitz L, Borg C, Francois E, Goere D, Huguet F, Peiffert D, Siproudhis L, Ducreux M, Bouche O (2017) Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP). Dig Liver Dis 49 (8):831-840. https://doi.org/10.1016/j.dld.2017.05.011

24.

Jones M, Hruby G, Solomon M, Rutherford N, Martin J (2015) The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol 22 (11):3574-3581. https://doi.org/10.1245/s10434-015-4391-9

25.

Mahmud A, Poon R, Jonker D (2017) PET imaging in anal canal cancer: a systematic review and meta-analysis. Br J Radiol 90 (1080):20170370. https://doi.org/10.1259/bjr.20170370

26.

Bhuva NJ, Glynne-Jones R, Sonoda L, Wong WL, Harrison MK (2012) To PET or not to PET? That is the question. Staging in anal cancer. Ann Oncol 23 (8):2078-2082. https://doi.org/10.1093/annonc/mdr599

27.

Wells IT, Fox BM (2012) PET/CT in anal cancer - is it worth doing? Clin Radiol 67 (6):535-540. https://doi.org/10.1016/j.crad.2011.10.030

28.

Agarwal A, Marcus C, Xiao J, Nene P, Kachnic LA, Subramaniam RM (2014) FDG PET/CT in the management of colorectal and anal cancers. AJR Am J Roentgenol 203 (5):1109-1119. https://doi.org/10.2214/ajr.13.12256

29.

Saboo SS, Zukotynski K, Shinagare AB, Krajewski KM, Ramaiya N (2013) Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up. Abdom Imaging 38 (4):728-735. https://doi.org/10.1007/s00261-012-9958-3

30.

AJCC Cancer Staging Manual (2017). 8 edn. Springer International Publishing,

31.

Parikh J, Shaw A, Grant LA, Schizas AM, Datta V, Williams AB, Griffin N (2011) Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up. European radiology 21 (4):776-785. https://doi.org/10.1007/s00330-010-1980-7

32.

Reginelli A, Granata V, Fusco R, Granata F, Rega D, Roberto L, Pellino G, Rotondo A, Selvaggi F, Izzo F, Petrillo A, Grassi R (2017) Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in detection, staging and assessment post treatment, in anal cancer. Oncotarget 8 (14):22980-22990. https://doi.org/10.18632/oncotarget.14946

33.

Otto SD, Lee L, Buhr HJ, Frericks B, Hocht S, Kroesen AJ (2009) Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging. J Gastrointest Surg 13 (7):1292-1298. https://doi.org/10.1007/s11605-009-0870-2

34.

Granata V, Fusco R, Reginelli A, Roberto L, Granata F, Rega D, Rotondo A, Grassi R, Izzo F, Petrillo A (2016) Radiological assessment of anal cancer: an overview and update. Infect Agent Cancer 11:52. https://doi.org/10.1186/s13027-016-0100-y

35.

Touboul E, Schlienger M, Buffat L, Lefkopoulos D, Pene F, Parc R, Tiret E, Gallot D, Malafosse M, Laugier A (1994) Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer 73 (6):1569-1579

36.

Frost DB, Richards PC, Montague ED, Giacco GG, Martin RG (1984) Epidermoid cancer of the anorectum. Cancer 53 (6):1285-1293

37.

Godlewski G, Prudhomme M (2000) Embryology and anatomy of the anorectum. Basis of surgery. The Surgical clinics of North America 80 (1):319-343

38.

Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D (2014) Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25 Suppl 3:iii10-20. https://doi.org/10.1093/annonc/mdu159

39.

Kochhar R, Plumb AA, Carrington BM, Saunders M (2012) Imaging of anal carcinoma. AJR Am J Roentgenol 199 (3):W335-344. https://doi.org/10.2214/ajr.11.8027

40.

Ryan DP, Willett CG (2018) Clinical features, staging, and treatment of anal cancer. https://www.uptodate.com/contents/clinical-features-staging-and-treatment-of-anal-cancer. Accessed December 4, 2018

41.

Roach SC, Hulse PA, Moulding FJ, Wilson R, Carrington BM (2005) Magnetic resonance imaging of anal cancer. Clin Radiol 60 (10):1111-1119. https://doi.org/10.1016/j.crad.2005.05.008

42.

Durot C, Dohan A, Boudiaf M, Servois V, Soyer P, Hoeffel C (2017) Cancer of the Anal Canal: Diagnosis, Staging and Follow-Up with MRI. Korean journal of radiology 18 (6):946-956. https://doi.org/10.3348/kjr.2017.18.6.946

43.

Torkzad MR, Kamel I, Halappa VG, Beets-Tan RG (2014) Magnetic resonance imaging of rectal and anal cancer. Magnetic resonance imaging clinics of North America 22 (1):85-112. https://doi.org/10.1016/j.mric.2013.07.007

44.

Benson AB, 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA (2018) Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN 16 (7):852-871. https://doi.org/10.6004/jnccn.2018.0060

45.

Winton E, Heriot AG, Ng M, Hicks RJ, Hogg A, Milner A, Leong T, Fay M, MacKay J, Drummond E, Ngan SY (2009) The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. British journal of cancer 100 (5):693-700. https://doi.org/10.1038/sj.bjc.6604897

46.

Wright JL, Patil SM, Temple LK, Minsky BD, Saltz LB, Goodman KA (2010) Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning. International journal of radiation oncology, biology, physics 78 (4):1064-1072

47.

Cummings BJ, Keane TJ, O’Sullivan B, Wong CS, Catton CN (1991) Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. International journal of radiation oncology, biology, physics 21 (5):1115-1125

48.

Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 14 (9):2527-2539. https://doi.org/10.1200/jco.1996.14.9.2527

49.

Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 15 (5):2040-2049. https://doi.org/10.1200/jco.1997.15.5.2040

50.

Northover J, Glynne-Jones R, Sebag-Montefiore D, James R, Meadows H, Wan S, Jitlal M, Ledermann J (2010) Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). British journal of cancer 102 (7):1123-1128. https://doi.org/10.1038/sj.bjc.6605605

51.

Chang GJ, Gonzalez RJ, Skibber JM, Eng C, Das P, Rodriguez-Bigas MA (2009) A twenty-year experience with adenocarcinoma of the anal canal. Dis Colon Rectum 52 (8):1375-1380. https://doi.org/10.1007/dcr.0b013e3181a79589

52.

Deutsch E, Lemanski C, Pignon JP, Levy A, Delarochefordiere A, Martel-Lafay I, Rio E, Malka D, Conroy T, Miglianico L, Becouarn Y, Malekzadeh K, Paris E, Juzyna B, Ezra P, Azria D (2013) Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial. Ann Oncol 24 (11):2834-2838. https://doi.org/10.1093/annonc/mdt368

53.

Eng C, Crane CH, Rosner GL, et al. (2005) A phase II study of capecitabine plus oxaliplatin and radiation therapy (XELOX-RT) in squamous cell carcinoma of the anal canal: a preliminary toxicity analysis. Proc ASCO/AGA/ASTRO/SSO GI Symposium 2:192 (abstr).

54.

Sebag-Montefiore D, Meadows HM, Cunningham D, Plowman PN, Hurman DC, Davidson N, Grieve R, Levine E, Glynne-Jones R (2012) Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 104 (2):155-160. https://doi.org/10.1016/j.radonc.2012.06.006

55.

Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, Haddock MG, Rotman M, Parikh PJ, Safran H, Willett CG (2013) RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. International journal of radiation oncology, biology, physics 86 (1):27-33. https://doi.org/10.1016/j.ijrobp.2012.09.023

Titel: MR staging of anal cancer: what the radiologist needs to know
verfasst von: Jennifer S. Golia Pernicka
Shannon P. Sheedy
Randy D. Ernst
Bruce D. Minsky
Dhakshinamoorthy Ganeshan
Gaiane M. Rauch
Publikationsdatum: 30.04.2019
Verlag: Springer US
Erschienen in: Abdominal Radiology / Ausgabe 11/2019
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-019-02020-4

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

MR staging of anal cancer: what the radiologist needs to know

Abstract

Neu im Fachgebiet Radiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update Radiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2019

A prospective feasibility study evaluating the role of multimodality imaging and liquid biopsy for response assessment in locally advanced rectal carcinoma

Tumor detectability and conspicuity comparison of standard b1000 and ultrahigh b2000 diffusion-weighted imaging in rectal cancer

Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer

Mucinous rectal cancer: concepts and imaging challenges

Primary and post-chemoradiotherapy staging using MRI in rectal cancer: the role of diffusion imaging in the assessment of perirectal infiltration

Current controversy, confusion, and imprecision in the use and interpretation of rectal MRI

Neu im Fachgebiet Radiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update Radiologie